Cancer drug Imbruvica approved by Therapeutic Goods Administration

By Lisa Wachsmuth
May 25 2015 - 6:00am
Breakthrough: Leukaemia survivor and CanSpeak chief executive John Stubbs welcomes the approval of Imbruvica, a new cancer-fighting medicine. Picture: SYLVIA LIBER
Breakthrough: Leukaemia survivor and CanSpeak chief executive John Stubbs welcomes the approval of Imbruvica, a new cancer-fighting medicine. Picture: SYLVIA LIBER

Thirroul leukaemia survivor John Stubbs says a new medicine is providing fresh hope in the fight against the most common form of the cancer.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Wollongong news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.